These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25548743)

  • 1. Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection.
    Cho YK; Kim YN; Song BC
    Clin Mol Hepatol; 2014 Dec; 20(4):368-75. PubMed ID: 25548743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis C in Spain: a retrospective study of 131 cases.
    Pérez-Álvarez R; García-Samaniego J; Solá R; Pérez-López R; Bárcena R; Planas R; Cañete N; Manzano ML; Gutiérrez ML; Morano L; Rodrigo L
    Rev Esp Enferm Dig; 2012 Feb; 104(1):21-8. PubMed ID: 22300113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.
    Hashem M; Zaghla H; Zakaria Z; Allam WR; Sameea EA; Mikhail NN; Sobhy M; Galal IF; Mokhtar Y; Hamdy S; Galal G; Abdelwahab SF; Waked I
    J Med Virol; 2018 Dec; 90(12):1841-1847. PubMed ID: 30011346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection.
    Beinhardt S; Payer BA; Datz C; Strasser M; Maieron A; Dorn L; Grilnberger-Franz E; Dulic-Lakovic E; Stauber R; Laferl H; Aberle JH; Holzmann H; Krall C; Vogel W; Ferenci P; Hofer H
    J Hepatol; 2013 Nov; 59(5):972-7. PubMed ID: 23850880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
    Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
    Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
    Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.
    Venturi C; Bueno J; Castells L; Quintero J; Casas I; Allende H; Martinez-Ibañez V; Charco R
    Liver Transpl; 2011 Dec; 17(12):1474-80. PubMed ID: 21932378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.
    Hwang SJ; Lee SD; Lu RH; Chu CW; Wu JC; Lai ST; Chang FY
    J Med Virol; 2001 Nov; 65(3):505-9. PubMed ID: 11596085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.
    Lewis-Ximenez LL; Lauer GM; Schulze Zur Wiesch J; de Sousa PS; Ginuino CF; Paranhos-Baccalá G; Ulmer H; Pfeiffer KP; Goebel G; Pereira JL; Mendes de Oliveira J; Yoshida CF; Lampe E; Velloso CE; Alves Pinto M; Coelho HS; Almeida AJ; Fernandes CA; Kim AY; Strasak AM
    Clin Infect Dis; 2010 May; 50(9):1222-30. PubMed ID: 20235831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
    Reesink HW; Fanning GC; Farha KA; Weegink C; Van Vliet A; Van 't Klooster G; Lenz O; Aharchi F; Mariën K; Van Remoortere P; de Kock H; Broeckaert F; Meyvisch P; Van Beirendonck E; Simmen K; Verloes R
    Gastroenterology; 2010 Mar; 138(3):913-21. PubMed ID: 19852962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.